Mammogen

🗓 Founded 2020👥 6 employees💰 Last funded Dec 2020
Biotechnology Research🌐 mammogen.bio
Website LinkedIn
Mammogen is a female-led precision health company dedicated to radically improving the detection, diagnosis and treatment of womens health-related diseases, and creating a diverse and thriving global community that encourages, empowers and uplifts women throughout the journey of survivorship, from end-to-never-end. Our flagship genTRU diagnostic program is a clinical-stage, patent-pending technology that measures changes in RNA expression patterns, found in both blood and saliva, to provide a highly accurate diagnosis of breast cancer consistently across all stages of disease. The genTRU-breast suite of diagnostics is intentionally designed to rule more of the right women into imaging and intervention much earlier and to rule more of the wrong women out of unnecessary procedures, and is positioned to unlock regular and reliable screening for hundreds of millions of women around the world.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Mammogen?
Mammogen has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Mammogen last raise funding?
The most recent investment in Mammogen recorded on gritt.io was in December 2020.
When was Mammogen founded?
Mammogen was founded in 2020.
What industry is Mammogen in?
Mammogen operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.